762P First results from phase II dose expansion cohort of transcon IL-2 β/γ in combination with standard of care chemotherapy for platinum resistant ovarian cancer (PROC) in the IL Believe trial
| Autor: | Yeku, O., Lee, J-Y., Rimmel, B., Kim, S-B., Van Den Mooter, T., Kichenadasse, G., Krapp, C., Slavsky, S., Torrejon Castro, D., Singel, S., Kwatra, V. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S577-S577 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|